CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research

Directions Website Contact the organization

CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research Revolutionizing the prevention, treatment, and management of STBBIs

The CTN+ prioritizes regional research capacity by fostering, developing, and supporting research teams in regions across Canada. These regional teams, which include researchers, community members, and Indigenous representation, champion the knowledge needs of those in their local communities. The focus on regional capacity and engagement is informed by the Network’s objective to uphold Indigenous rights and move towards truth and reconciliation, recognizing the power of research and knowledge mobilization to improve health equity across the country.

CTN+ researcher Dr. Elisabeth McClymont is the first author on the longest study to date of the in women living with...
10/08/2026

CTN+ researcher Dr. Elisabeth McClymont is the first author on the longest study to date of the in women living with HIV. The study (CTN 236) finds the vaccine offers long-term protection.

Human papillomavirus (HPV) causes 99% of all cervical cancer. Women living with HIV have higher rates of HPV infection and associated diseases. Women living with HIV have higher rates of human papillomavirus (HPV) infection and associated diseases. This makes understanding the impact of HPV vaccines on this population vital for eliminating cervical cancer.

• This study recruited 228 girls and women with HIV from clinics across Canada.
• Participants received 3 doses of the quadrivalent HPV vaccine at 0, 2, and 6 months. 
• Every 6–12 months, participants underwent testing to see how their immune system was responding and if they had been infected with HPV.
• The study ran from July 1, 2008, to June 27, 2019. 
• Researchers found that the HPV vaccine produced a strong and sustained immune response against HPV.
• They also found low rates of HPV among participants who received all 3 vaccine doses, and did not already have the strains of HPV targeted by the vaccine.

This study shows how HPV vaccination is crucial for lowering HPV transmission and cervical cancer rates among women and girls living with HIV.

10/08/2026

CBRC and Gay Men's Sexual Health Alliance invites Ontario healthcare providers to Come Together: Enhancing Our Collective Capacity to Address HIV and STBBIs Among GBT2Q Communities.

Key topics include the emerging HIV PrEP landscape, relational approaches to serving Two-Spirit and Indigenous communities, and serving newcomer communities.

Space is limited — we encourage you to register by October 15.
Full details here: https://www.cbrc.net/summit_2026_ancillary

If you have any questions, please contact [email protected].

Research has the wonderful power to improve people’s lives. It also has the capacity to do great harm. For over three hu...
09/30/2026

Research has the wonderful power to improve people’s lives. It also has the capacity to do great harm. For over three hundred years, medical research in Canada was often used as a tool of colonial violence against the Indigenous Peoples who had lived on this land since time immemorial.

On September 30th, The National Day for Truth & Reconciliation, we recognise the truth of our history by paying our respects to those who were lost and honouring the resilience of Survivors. We also re-affirm our commitment to doing better. The CTN+ remains dedicated to empowering First Nations, Métis, and Inuit within the space of s*xually transmitted and blood born disease (STBBI) and HIV research. We continue to work with Indigenous partners to center the priorities, expertise, and cultural heritage of the Indigenous communities who participate in our studies.

We must learn from the past to improve our future.

A recent B.C. study, co-written by previous CTN+ postdoc fellow Dr. Katherine Kooij, compared health indicators among pe...
09/25/2026

A recent B.C. study, co-written by previous CTN+ postdoc fellow Dr. Katherine Kooij, compared health indicators among people with HIV based on s*x assigned at birth.

It found that at ages 20 and 40, those assigned male at birth had more years free from comorbidities. Researchers noted higher substance use among study participants assigned female at birth.

Read the full write up by CATIE :
https://tinyurl.com/5ubbkw6b

Do you strive for a better world? ✋Then you might want to join the STBBI-STRIVE training program!Gain foundational data ...
09/24/2026

Do you strive for a better world? ✋

Then you might want to join the STBBI-STRIVE training program!

Gain foundational data literacy skills related to research using administrative , while meeting and collaborating with a network of ainees, mentors, alumni and partners through seminars and workshops.

STRIVE is open to applicants from across Canada, with preference given to those based in British Columbia and the Yukon.

📆 Apply by November 1st, 2026.

Learn more: www.ctn.ca/strive

Le VPH chez les personnes vivant avec le VIH : du risque de cancers au dépistage et à la prévention Animé par le Dr Alex...
09/23/2026

Le VPH chez les personnes vivant avec le VIH : du risque de cancers au dépistage et à la prévention

Animé par le Dr Alexandra de Pokomandy et le Dr Sean Yaphé, chercheurs au CTN+, ce webinaire organisé par le CATIE explore le lien entre le papillomavirus humain (HPV) et le risque accru de cancers de l'anus, des organes génitaux et de la gorge chez les personnes vivant avec le VIH. Cette session permet également de mieux comprendre les données actuelles sur les cancers liés au HPV, les méthodes de dépistage et les obstacles à l'accès à ces derniers.

📆 27 octobre 2026
⏲️De 13 h à 14 h (heure de la côte Est)

Inscrivez-vous ici : https://tinyurl.com/5f2ht9fh

The Engage Cohort Study team, including CTN+ researchers Drs. Paolo Palma, Nathan Lachowsky, Darrell Tan, and Trevor Har...
09/22/2026

The Engage Cohort Study team, including CTN+ researchers Drs. Paolo Palma, Nathan Lachowsky, Darrell Tan, and Trevor Hart, modelled direct and indirect within- and between-person effects of HIV treatment attitudes and PrEP use on condomless a**l s*x and incident B-STIs among 1863 HIV-negative gay, bis*xual, and other men who have s*x with men.

They found found direct within-person effects of treatment attitudes and use on incident B-STIs, such that participants were more likely to report incident B-STIs at time points if they reported using PrEP and being more optimistic about HIV treatment.

Read the full paper: https://tinyurl.com/mpfnnfh2

This October, the Michael Smith Genome Science Centre is pleased to be hosting its annual Collaborator Forum on Thursday...
09/21/2026

This October, the Michael Smith Genome Science Centre is pleased to be hosting its annual Collaborator Forum on Thursday October 29th in Vancouver.

Where Omics Expertise Meets Opportunity brings together researchers, collaborators, technology partners, and the broader genomics community for a day of science, technology, innovation, and connection. We look forward to exciting discussions in curated panels along with networking and posters.

Register here: https://tinyurl.com/5n7p4jyr

💡Postdoc Spotlight: Dr. Ngozi Joe-Ikechebelu Having joined the CTN+ in 2025 as the first Jacquie Sas Postdoctoral Fellow...
09/17/2026

💡Postdoc Spotlight: Dr. Ngozi Joe-Ikechebelu

Having joined the CTN+ in 2025 as the first Jacquie Sas Postdoctoral Fellow, she's using her role to take a deep dive into the ‘Knowledge, Attitude and Practices Regarding HIV and HIV Among Nigerian Youth in Nigeria and Canada.’

“Motivated by a commitment to social justice, I aim to break systemic barriers, reduce stigma, and improve health care access through culturally specific, community-based strategies that boost health outcomes and quality of life for ethnoracialized communities,” she said.

Read more about Dr. Joe-Ikechebelu's research: https://bit.ly/4rfMTMl

Address

Vancouver, BC

Website

Alerts

Be the first to know and let us send you an email when CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research:

Shortcuts

Share